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Askin’stumorisararetumorarisingfromthechestwall.ItisasubsetofEwingsarcomacharacterizedhistologicallybythepresence
of small round blue cells. It is a highly malignant tumor with guarded prognosis, which is dependent upon the extension of tumor
at the time of diagnosis. A dual paper of Askin’s tumors in young boys is being presented here.
1.Introduction
Ewing sarcoma comprises of tumors which are characterized
by small round blue cells. These include classical Ewing
sarcoma of bone, extraskeletal Ewing sarcoma, Askin’s tumor
of the thoracic wall, and peripheral primitive neuroecto-
dermal tumor [1]. Askin’s tumor is a peripheral primitive
neuroectodermal tumor of the thoracopulmonary region
involving the chest wall [2]. Considering its rarity, we are
reporting two cases of young boys who presented with
respiratory symptoms and were diagnosed as Askin’s tumor
subsequently.
Case 1. 3 years old male toddler, presented with 15 days of
cough and 1 day of chest pain, breathlessness, and low-grade
fever. He had no other associated complaints, and his past
historywasunremarkable.ChestradiographPAviewshowed
a large homogenous opacity on right upper lobe, suggestive
of a mass lesion (Figure 1). CT scan revealed a large mass
(6.1cm × 5.6cm × 5.1cm) which was merging medially
with the mediastinum and laterally, anteriorly, posteriorly
andsuperiorlywiththethoracicwall,involvingposteriorand
lateral parts of right 1st and 2nd ribs. Fine needle aspiration
cytology (FNAC) from the mass lesion showed small blue
round cells with monomorphous salt and pepper appearing
chromatin and large and inconspicuous nuclei, suggestive
of primitive neuroectodermal tumor—likely Askin’s tumor
(Figure 2). For diagnostic consideration, biopsy was taken
from the mass. It revealed small cells with large nuclei and
scantycytoplasm,withregularchromatinandinconspicuous
nucleoli. Considering the site and histology, diagnosis of
Askin’s tumor was made. He was started chemotherapy with
vincristine, adriamycin and cyclophosphamide (VAC), and
Ifosfamide and etoposide (IE) alternating 3 weekly cycles as
per round cell tumor II (RCT II) protocol [3].
The tumor regressed signiﬁcantly with 8 cycles of
chemothearpy. Surgery was undertaken after the course of
chemotherapy. Operative ﬁndings showed tumor which was
arising from the 1st rib, stuck to the apex of the right lung.
There was also intense desmoplastic reaction surrounding
the tumor, and adhesions were present between the tumor
and the right subclavian vessel and superior venacava.
Thoracotomy with excision of the tumor and resection
of the ﬁrst rib was done, preserving subclavian vein and
brachial plexus. There were no postoperative complications.
Postoperative histopathological examination of the mass
s h o w e ds m a l lr o u n db l u ec e l lt u m o r sw i t hh y p e r c h r o m a t i c
nuclei and scanty cytoplasm with tiny foci of calciﬁcations.2 International Journal of Pediatrics
Figure 1: Chest X-ray of Case 1 at the presentation.
Figure 2: FNAC from the lesion in Case 1 showing the small round
blue cells (×400 magniﬁcation).
Immunohistochemistry was strongly positive for CK and
CD-99 and negative for LCA and CD-34 (Figure 3).
Postoperatively, he was given ifosfamide, carboplatin,
and etoposide (ICE) chemotherapy [4]. Despite adjuvant
chemotherapy, he had a relapse after a month of surgery, in
the form of right supraclavicular lymphadenopathy. FNAC
result from the lymph node was consistent with Askin’s
tumor. His chemotherapy was then changed to etoposide,
vincristine, adriamycin, ifosfamide, actinomycin D (EVAIA)
protocol[5].However,despite2cyclesofEVAIA,theswelling
remained progressive. Considering his poor response, the
protocol was changed to cyclophosphamide, vincristine, and
dactinomycin (CVD) [6]. He showed response to CVD in
the form that his swelling has regressed, but local pain over
the operated site has remained persistent. Presently he is
undergoing the 6th cycle of CVD and has remained relatively
asymptomatic. The plan is to continue CVD cycle for next 12
cycles and reassess further.
Figure 3: Immunohistochemistry from the lesion showing CK and
CD 99 positive in Case 1 (×400 magniﬁcation).
Figure 4: Histopathlogical examination of the biopsy in Case 2
showing sheets of small round blue cells (×400 magniﬁcation).
Case 2. 9-year-old boy had presented with chest pain
and fever of 7 days duration. There was no history of
breathlessness, cough, hemoptysis, or weight loss. His past
history and family history were unremarkable. Radiograph
of the chest PA view showed large homogenous opacity
covering almost the entire right hemithorax. CT scan chest
delineated a large mass (9.5cm × 4.5cm × 7.3cm) along the
right posterolateral chest wall which was causing scalloping
of the inner surface of the 8th rib with obliteration of the
extrapleural fat in places with free well deﬁned and irregular
border medially. FNAC from the lesion showed small round
blue cells, with scanty cytoplasm and relatively large nuclei.
Biopsy of the lesion showed small round blue cells in sheets
with ill-deﬁned rosette-like structures, histomorphologically
peripheral neuroectodermal tumor-possibly Askin’s tumor
(Figure 4). Immunohistochemistry of the tumor cells was
CD-99, synaptophysin, chromoganin focal positive, and
desmin, SMA, CK, and LCA negative.
He was given chemotherapy with vincristine, adriamycin
and cyclophosphamide (VAC), alternating with ifosfamide
and etoposide (IE) as per RCT II protocol [3]. After
completion of 4 cycles, the mass showed signiﬁcant regres-
sion. Postchemotherapy, he was taken up for surgery. Per
operatively the tumor mass was seen on parietal pleura,
extending from the 5th to the 8th ribs and adherent to theInternational Journal of Pediatrics 3
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Figure 5: Chest X ray postsurgery in Case 2.
chest wall. Wide local excision with en bloc excision of the
5th, 6th, 7th, and 8th ribs was done, leaving behind a clear
2cm healthy margin. The resected region was reconstructed
with bone cement and prolene mesh. The chest radiograph
PA view postsurgery is shown (Figure 5). After successful
surgery, he was put on alternating cycles of vincristine,
adriamycin and cyclophosphamide (VAC) alternating with
cyclophosphamide, vincristine, and dactinomycin (CVD).
Presently, he has completed 6 cycles of chemotherapy and
has remained relapse-free and asymptomatic. We plan to
continue chemotherapy to complete 12 cycles and reevaluate
further then.
2. Discussion
Askin’s tumor is a subset of Ewing’s sarcoma which arises
from the chest wall. It is characterized histologically by
features of small round blue cell tumors. It was described by
Askin et al. in 1979 [7]. It is more frequent in males than in
females (1.5:1). Ewing sarcoma is the second most common
malignant bone tumor in childhood and sixth most frequent
malignant bone tumor. Ewing sarcoma is a rare tumor with
incidence of 2.9 per million in populations younger than
20 years and it rarely presents in adults more than 30 years
[8–10].
Askin’stumorisgeneticallydeﬁnedbyreciprocaltranslo-
cation t(11:22) (q24:q12) with EWS-FLI-1 fusion gene
[1, 11, 12]. It is characterized as grey white tumor with
variousnecrotic,hemorrhagicorcysticpartsingrosssection.
Histologically, it is distinguished by typical small round blue
cells of monomorphous appearance. It is believed to be of
neural crest origin [4, 7–9, 13].
Askin’s tumor usually presents with common respiratory
symptoms. It may include cough, chest pain, fever, breath-
lessness,andsoforth.Localpainmaybepresentwhichmight
reduce in intensity at night but not disappear completely. It
maypresentwithlocalparaesthesiaandrarelyaspathological
fracture or metastasis related symptoms [1, 9]. In the cases
presented, the manifestation was purely like any lower respi-
ratory tract infections. High index of suspicion is required
in such scenario. However, poor response to antibiotics,
any associated alarming features and relatively poor general
condition of the patient should hint towards more sinister
underlying pathology. In doubtful cases, it would be more
prudent to investigate aggressively and rule out any serious
condition.
Radiography of the chest in Askin’s tumor may show
classicalonion-peelappearanceofthetumororjusthomoge-
nous opacity [1, 9]. In both of our cases, it was just
homogenous opacity. Magnetic resonance imaging is supe-
rior to computed tomography scan in delineating the mass
accurately because of its intrinsic high-contrast resolution,
multiplanar capability, and because of its allowance of a
clearassessmentofchestwallmuscleinvolvement[14].Non-
Hodgkin’s lymphoma, small cell osteosarcoma, metastatic
neuroblastoma and so forth, should be considered as dif-
ferentials during histological study [1, 9, 15]. Immunohisto-
chemistry is used to diﬀerentiate and conﬁrm the diagnosis
of peripheral neuroectodermal tumors from other round cell
tumors [8–11].
The treatment includes chemotherapy, radiotherapy and
surgery. Surgical therapy has the most important implica-
tion; however, because of its position, surgery has to be
individualized.Completesurgicalresectionisassociatedwith
a survival advantage [1, 9]. Overall, 5-year survival rate is
70%, prognosis being dependent upon the tumor extension
at diagnosis. In our cases here, the clear surgical resection
was not possible in the ﬁrst case due to the anatomical
complexities of the involved structures. The relapses which
the ﬁrst case had could be contributed perhaps to the
residual tumor which may have been left during the surgery.
However, the second case, which had wide local excision of
the tumor, showed better response in the form of no relapses
so far. However, the cases need to be followed up. Ewing
sarcoma is known to be radiosensitive, but raodiotherapy
has to be individualized, especially in younger age group,
considering the chest wall deformity of the growing bones
as well as neurolodevelopmental complications which may
be associated with radiotherapy. Radiotherapy was avoided
in our cases in view of the younger age group. Postoperative
adjuvant chemotherapy and radiotherapy are employed to
achieve local control, depending upon the surgical as well
as metastatic status. Important complications during treat-
ment include relapses and musculoskeletal abnormalities
postsurgery [9].
3. Conclusion
Askin’s tumor is a rare tumor of childhood which usually
presents with common respiratory symptoms. Pediatrician
must be far sighted to suspect this rare entity with such
common presentations. It would require a high index of
suspicion on behalf of the general pediatrician for the
early recognition of this tumor so that chances of better
outcome and prognosis shall be there. However, considering
its aggressive nature, complicated course and recurrence
tendency, long term followup is warranted.4 International Journal of Pediatrics
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